Genetic prodrug activation therapy
Lancet
.
1997 Dec;350(9094):1793-4.
doi: 10.1016/s0140-6736(05)63633-1.
Authors
L A Martin
1
,
R Vile
,
N R Lemoine
,
K Sikora
,
H S Pandha
Affiliation
1
Imperial Cancer Research Fund, Imperial College School of Medicine, Hammersmith Hospital, London, UK.
PMID:
9428248
DOI:
10.1016/s0140-6736(05)63633-1
No abstract available
MeSH terms
Animals
Humans
Mice
Neoplasms, Experimental / drug therapy*
Neoplasms, Experimental / genetics
Prodrugs / therapeutic use*
Rats
Transcriptional Activation / genetics*
Substances
Prodrugs